Adaptimmune Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Adaptimmune Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10648
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Adaptimmune Ltd (Adaptimmune) a subsidiary of Adaptimmune Therapeutics plc operates as a clinical trials and pipeline company. The company engaged in developing T-cell receptors for T-cell therapy and SPEAR TCR therapies. Its clinical trials include synovial sarcoma trial, multiple myeloma trial, ovarian cancer trial, non-small cell lung cancer (NSCLC). In addition, it also provides pipelines such as MAGE-A10, MAGE-A4, AFP and NY-ESO. Adaptimmune is headquartered in Abingdon, Oxfordshire, the UK.

Adaptimmune Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adaptimmune Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adaptimmune Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adaptimmune Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adaptimmune Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adaptimmune Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Adaptimmune Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Adaptimmune Raises USD104 Million in Series A Venture Financing 10
Licensing Agreements 12
GlaxoSmithKline Exercises Licensing Agreement with Adaptimmune 12
Adaptimmune Enters Into Licensing Agreement With Life Technologies 14
Adaptimmune Ltd – Key Competitors 15
Adaptimmune Ltd – Key Employees 16
Adaptimmune Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Aug 02, 2018: Adaptimmune Reports Second Quarter 2018 Financial Results and Business Update 18
May 09, 2018: Adaptimmune Reports First Quarter 2018 Financial Results and Business Update 20
Other Significant Developments 23
Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Adaptimmune Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Adaptimmune Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adaptimmune Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adaptimmune Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adaptimmune Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Adaptimmune Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Adaptimmune Raises USD104 Million in Series A Venture Financing 10
GlaxoSmithKline Exercises Licensing Agreement with Adaptimmune 12
Adaptimmune Enters Into Licensing Agreement With Life Technologies 14
Adaptimmune Ltd, Key Competitors 15
Adaptimmune Ltd, Key Employees 16
Adaptimmune Ltd, Other Locations 17

List of Figures
Adaptimmune Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Adaptimmune Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Adaptimmune Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Adaptimmune Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Adaptimmune Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adaptimmune Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Adaptimmune Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adaptimmune Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Adaptimmune Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PanOptica Inc-製薬・医療分野:企業M&A・提携分析
    Summary PanOptica Inc (PanOptica) is a biopharmaceutical company that develops new ocular therapies in the field of ophthalmology. The company concentrates on candidates that are at or near the investigational new drug application stage. It licenses and develops novel therapeutics that can improve e …
  • Green Plains Inc (GPRE):企業の財務・戦略的SWOT分析
    Green Plains Inc (GPRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Live Nation Entertainment, Inc.:企業のM&A・事業提携・投資動向
    Live Nation Entertainment, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Live Nation Entertainment, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Campofrio Food Group, S.A.:戦略・SWOT・企業財務分析
    Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Kayne Anderson Capital Advisors LP:企業のM&A・事業提携・投資動向
    Kayne Anderson Capital Advisors LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kayne Anderson Capital Advisors LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Voyager Therapeutics Inc (VYGR):企業の財務・戦略的SWOT分析
    Summary Voyager Therapeutics Inc (Voyager) is a clinical-stage gene therapy company that develops treatments for patients suffering from severe neurological diseases. The company provides treatment for adeno-associated virus gene therapy field by selecting, designing and manufacturing vectors. Its c …
  • Sungrow Power Supply Co Ltd (300274):企業の財務・戦略的SWOT分析
    Summary Sungrow Power Supply Co Ltd (Sungrow) is a renewable energy company that manufactures power supply equipment for solar PV and wind power projects. The company's products include central inverter, string inverter, storage systems and accessories. It offers services such as construction, devel …
  • NanoRepro AG (NN6):医療機器:M&Aディール及び事業提携情報
    Summary NanoRepro AG (NanoRepro) is a manufacturer of fast-diagnostics and nutritional food supplements for home and clinical use. The company offers wide range of rapid diagnostic tests products in the areas of family planning, disease detection (preventive healthcare), food intolerances, allergies …
  • Hyundai Heavy Industries Co Ltd (009540):電力:M&Aディール及び事業提携情報
    Summary Hyundai Heavy Industries Co Ltd (HHI) is one of the leading shipbuilding companies in the world. HHI manufactures VLCCs, containerships, P/C ships, LNG carriers, and warships. Its offering also includes combined cycle power plant, thermal power plant, oil and gas processing plant, LNG plant, …
  • BELLUS Health Inc (BLU)-製薬・医療分野:企業M&A・提携分析
    Summary BELLUS Health Inc (BELLUS Health) is a biopharmaceutical development company, which focuses on developing drugs for rare diseases. The company’s pipeline products include BLU-5937 for chronic cough, Shigamab for STEC related hemolytic syndrome (sHUS); KIACTA for the treatment of a second ind …
  • WH Ireland Group Plc (WHI):企業の財務・戦略的SWOT分析
    WH Ireland Group Plc (WHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Molkerei Meggle Wasserburg GmbH & Co. KG:企業の戦略・SWOT・財務情報
    Molkerei Meggle Wasserburg GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Molkerei Meggle Wasserburg GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Enerjisa Enerji AS (ENJSA):企業の財務・戦略的SWOT分析
    Enerjisa Enerji AS (ENJSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Citrix Systems Inc (CTXS):企業の財務・戦略的SWOT分析
    Citrix Systems Inc (CTXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Kirby Corp (KEX):企業の財務・戦略的SWOT分析
    Kirby Corp (KEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ostfold Energi AS:企業の戦略的SWOT分析
    Ostfold Energi AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • China General Plastics Corp (1305):企業の財務・戦略的SWOT分析
    Summary China General Plastics Corp (CGPC), a subsidiary of USI Group is a chemical company that manufactures PVC resins. The company's products include poly vinyl chloride resins, raw materials, vinyl films, films and sheet products, construction products, leather products, and house ware products. …
  • The Lubrizol Corporation:企業の戦略・SWOT・財務情報
    The Lubrizol Corporation - Strategy, SWOT and Corporate Finance Report Summary The Lubrizol Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • NuVasive Inc (NUVA):企業の製品パイプライン分析2018
    Summary NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimall …
  • ARC Resources Ltd (ARX):企業の財務・戦略的SWOT分析
    ARC Resources Ltd (ARX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆